( Diosmin)
important information for the patient.
This medicine should always be used exactly as described in the patient leaflet, or as directed by
the doctor or pharmacist.
Otrex 600 tablet contains 600 mg of diosmin. The medicine increases the tension of venous vessel walls,
causes normalization of vessel permeability and has a protective effect on vessel walls (increases
the resistance of small blood vessels).
Indications for use of Otrex 600:
Warnings and precautions:
No data are available.
08583
The doctor or pharmacist should be informed about all medicines currently being taken by the patient
or recently taken, as well as any medicines that the patient plans to use.
Interactions between Otrex 600 and other medicines are not known.
In pregnancy and during breastfeeding, or if pregnancy is suspected or planned, the doctor or pharmacist should be consulted before using this medicine.
The medicine may be used during pregnancy only if necessary.
Due to the lack of data on the penetration of Otrex 600 into breast milk, the use of the medicine during breastfeeding is not recommended.
The medicine has no effect on the ability to drive and use machines.
This medicine should always be used exactly as described in the patient leaflet, or as directed by
the doctor or pharmacist. In case of doubts, the doctor or pharmacist should be consulted.
The medicine is administered orally.
Venous circulation failure of the lower limbs:
the usual dose of the medicine is 1 tablet per day, in the morning, on an empty stomach.
Exacerbation of hemorrhoid symptoms:
the usual dose of the medicine is 2 to 3 tablets per day, during meals.
In case of taking a higher dose of the medicine than recommended, the doctor or pharmacist should be consulted.
Symptoms of overdose of Otrex 600 are not known.
A double dose should not be taken to make up for a missed dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rarely, gastrointestinal disorders (nausea, vomiting) may occur.
If any side effects occur, including any side effects not listed in the leaflet, the doctor or pharmacist should be informed. Side effects can be reported directly to: Department of Monitoring of Adverse Reactions to Medicinal Products
Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: + 48 22 49 21 301
Fax: + 48 22 49 21 309
e-mail: ndl@urpl.gov.pl
Reporting side effects will help to gather more information on the safety of the medicine.
08583
The medicine should be stored in a place that is out of sight and reach of children.
The medicine should be stored at a temperature below 25°C.
The medicine should not be used after the expiry date stated on the carton after "expiry date". The expiry date refers to the last day of the stated month.
Medicines should not be disposed of via wastewater or household waste. The pharmacist should be asked how to dispose of medicines that are no longer used. This will help protect the environment.
Otrex 600 tablets are oblong, gray-yellow or light yellow with a dividing groove on both sides.
The tablets are packaged in blisters placed in cardboard cartons. The packages contain 15
and 30 tablets.
Responsible entity:
Stragen France SAS
30 rue Edouard Nieuport
69008 Lyon
France
Manufacturer:
Phyteo Laboratoire
11, rue de Montbazon
37260 Monts
France
Date of leaflet preparation: February 2020
08583
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.